Delivery Order SPE2DB24D9222-SPE2DB25FAZBF

Award Date 10/17/24
Potential Completion Date 11/7/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $38,347.10 to the woman-owned small business DMS Pharmaceutical Group Inc. based in Park Ridge, Illinois. The order is for the pharmaceutical product Rituxan 500 mg/50 ml vial and has a completion date of February 28, 2023. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,691.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4565781429 RITUXAN 500 MG/50 ML VIAL 50ML to DLA's Medical Supply Chain division. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $33,760.87 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Rituxan 500 mg/50 ml vial, a pharmaceutical product used in medical care. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract #SPE2DB23D4600082013, which has a ceiling value of up to...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,276.68 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4564153966 - RITUXAN 500 MG/50 ML VIAL 50ML, with a period of performance through April 19, 2024. This award is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with DLA, which has a ceiling value of up to $4,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order worth $5,965.88 for the supply of Rituxan, a 500 mg/50 ml vial medication, with a period of performance through March 14, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,138.34 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to provide Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. The contract is not associated with a specific set-aside designation, which allows DMS Pharmaceutical Group to leverage its woman-owned small business...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,914.16 firm fixed-price delivery order is for the supply of 4554941547 Rituxan 500 mg/50 ml vials. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,879.94 firm fixed-price delivery order contract is for the provision of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The award is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,345.85 contract is for the supply of Rituxan 500 mg/50 ml vials. This delivery order is issued against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables the agency to order a broad range of pharmaceutical...
  • SPE2DB24D9222
    Indefinite Delivery Contract
  • SPE2DB24D9222-SPE2DB25FAZBF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 1/16/25, 9:08 AM